{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:33:59Z","timestamp":1767598439772,"version":"3.40.3"},"publisher-location":"Cham","reference-count":19,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031090011"},{"type":"electronic","value":"9783031090028"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-09002-8_33","type":"book-chapter","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:05:34Z","timestamp":1657800334000},"page":"367-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of\u00a0MR Preprocessing Strategies and\u00a0Sequences for\u00a0Radiomics-Based MGMT Prediction"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-5985","authenticated-orcid":false,"given":"Daniel","family":"Abler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-5821","authenticated-orcid":false,"given":"Vincent","family":"Andrearczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-6916","authenticated-orcid":false,"given":"Valentin","family":"Oreiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-6053","authenticated-orcid":false,"given":"Javier Barranco","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-4219","authenticated-orcid":false,"given":"Diem","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-1522","authenticated-orcid":false,"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2434-9990","authenticated-orcid":false,"given":"Mauricio","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-0304","authenticated-orcid":false,"given":"Adrien","family":"Depeursinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"33_CR1","unstructured":"Baid, U., et al.: The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation and Radiogenomic Classification. arXiv:2107.02314, September 2021"},{"key":"33_CR2","doi-asserted-by":"publisher","unstructured":"Bakas, S., et al.: Advancing the cancer genome atlas glioma MRI collections with expert segmentation labels and radiomic features. Sci. Data 4(1), 1\u20133 (2017). https:\/\/doi.org\/10.1038\/sdata.2017.117","DOI":"10.1038\/sdata.2017.117"},{"key":"33_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602321","author":"NG Burnet","year":"2005","unstructured":"Burnet, N.G., Jefferies, S.J., Benson, R.J., Hunt, D.P., Treasure, F.P.: Years of life lost (YLL) from cancer is an important measure of population burden\u2013and should be considered when allocating research funds. Br. J. Cancer (2005). https:\/\/doi.org\/10.1038\/sj.bjc.6602321","journal-title":"Br. J. Cancer"},{"issue":"7","key":"33_CR4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3174\/ajnr.A5667","volume":"39","author":"P Chang","year":"2018","unstructured":"Chang, P., et al.: Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am. J. Neuroradiol. 39(7), 1201\u20131207 (2018). https:\/\/doi.org\/10.3174\/ajnr.A5667","journal-title":"Am. J. Neuroradiol."},{"issue":"2","key":"33_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R.J., Kinahan, P.E., Hricak, H.: Radiomics: images are more than pictures. Data. Radiol. 278(2), 563\u2013577 (2016). https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Data. Radiol."},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/j.wneu.2019.08.232","volume":"132","author":"G Hajianfar","year":"2019","unstructured":"Hajianfar, G., et al.: Noninvasive O6 methylguanine-DNA methyltransferase status prediction in glioblastoma multiforme cancer using magnetic resonance imaging radiomics features: univariate and multivariate radiogenomics analysis. World Neurosurg. 132, e140\u2013e161 (2019). https:\/\/doi.org\/10.1016\/j.wneu.2019.08.232","journal-title":"World Neurosurg."},{"key":"33_CR7","doi-asserted-by":"publisher","unstructured":"Kihira, S., et al.: Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion. Neuro-Oncol. Adv. 3(1), vdab051 (2021). https:\/\/doi.org\/10.1093\/noajnl\/vdab051","DOI":"10.1093\/noajnl\/vdab051"},{"key":"33_CR8","doi-asserted-by":"publisher","unstructured":"Korfiatis, P., et al.: MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas: MRI texture features to predict MGMT methylation status. Med. Phys. 43(6Part1), 2835\u20132844 (2016). https:\/\/doi.org\/10.1118\/1.4948668","DOI":"10.1118\/1.4948668"},{"issue":"10145","key":"33_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe, S., Perry, A., Butowski, N.A.: Primary brain tumours in adults. The Lancet 392(10145), 432\u2013446 (2018). https:\/\/doi.org\/10.1016\/S0140-6736(18)30990-5","journal-title":"The Lancet"},{"issue":"9","key":"33_CR10","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1007\/s00330-017-5302-1","volume":"28","author":"Z-C Li","year":"2018","unstructured":"Li, Z.-C., et al.: Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: a multicentre study. Eur. Radiol. 28(9), 3640\u20133650 (2018). https:\/\/doi.org\/10.1007\/s00330-017-5302-1","journal-title":"Eur. Radiol."},{"key":"33_CR11","doi-asserted-by":"publisher","unstructured":"Lowekamp, B.C., Chen, D.T., Ib\u00e1\u00f1ez, L., Blezek, D.: The design of SimpleITK. Front. Neuroinform. 7, 1\u20138 (2013). https:\/\/doi.org\/10.3389\/fninf.2013.00045","DOI":"10.3389\/fninf.2013.00045"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mri.2020.09.017","volume":"74","author":"Y Lu","year":"2020","unstructured":"Lu, Y., et al.: Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma. Magn. Reson. Imaging 74, 161\u2013170 (2020). https:\/\/doi.org\/10.1016\/j.mri.2020.09.017","journal-title":"Magn. Reson. Imaging"},{"issue":"10","key":"33_CR13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1109\/TMI.2014.2377694","volume":"34","author":"BH Menze","year":"2015","unstructured":"Menze, B.H., et al.: The multimodal brain tumor image segmentation benchmark (BRATS). IEEE Trans. Med. Imaging 34(10), 1993\u20132024 (2015). https:\/\/doi.org\/10.1109\/TMI.2014.2377694","journal-title":"IEEE Trans. Med. Imaging"},{"issue":"4","key":"33_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","volume":"18","author":"AP Patel","year":"2019","unstructured":"Patel, A.P., et al.: Global, regional, and national burden of brain and other CNS cancer, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurol. 18(4), 376\u2013393 (2019). https:\/\/doi.org\/10.1016\/S1474-4422(18)30468-X","journal-title":"The Lancet Neurol."},{"key":"33_CR15","doi-asserted-by":"publisher","unstructured":"Reinhold, J.C., Dewey, B.E., Carass, A., Prince, J.L.: Evaluating the impact of intensity normalization on MR image synthesis. In: Angelini, E.D., Landman, B.A. (eds.) Medical Imaging 2019: Image Processing. p. 126. SPIE, San Diego, United States, March 2019. https:\/\/doi.org\/10.1117\/12.2513089","DOI":"10.1117\/12.2513089"},{"issue":"2","key":"33_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/nop020","volume":"12","author":"AL Rivera","year":"2010","unstructured":"Rivera, A.L., et al.: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-Oncol. 12(2), 116\u2013121 (2010). https:\/\/doi.org\/10.1093\/neuonc\/nop020","journal-title":"Neuro-Oncol."},{"key":"33_CR17","doi-asserted-by":"publisher","unstructured":"Suh, C., Kim, H., Jung, S., Choi, C., Kim, S.: Clinically relevant imaging features for MGMT promoter methylation in multiple glioblastoma studies: a systematic review and meta-analysis. Am. J. Neuroradiol. 39, 1439\u20131445 (2018). https:\/\/doi.org\/10.3174\/ajnr.A5711","DOI":"10.3174\/ajnr.A5711"},{"issue":"21","key":"33_CR18","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJ van Griethuysen","year":"2017","unstructured":"van Griethuysen, J.J., et al.: Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77(21), e104\u2013e107 (2017). https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res."},{"key":"33_CR19","doi-asserted-by":"publisher","unstructured":"Xi, Y.b., et al.: Radiomics signature: a potential biomarker for the prediction of MGMT promoter methylation in glioblastoma: GBM radiomics features reflect MGMT. J. Magn. Reson. Imaging 47(5), 1380\u20131387 (2018). https:\/\/doi.org\/10.1002\/jmri.25860","DOI":"10.1002\/jmri.25860"}],"container-title":["Lecture Notes in Computer Science","Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-09002-8_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:10:21Z","timestamp":1657800621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-09002-8_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031090011","9783031090028"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-09002-8_33","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 July 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"BrainLes","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International MICCAI Brainlesion Workshop","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2021","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"27 September 2021","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"27 September 2021","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"7","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iwb2021","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.brainlesion-workshop.org\/?msclkid=7759e32ed14111ecba82c5ba435279db","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Double-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"CMT","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"151","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"91","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"0","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"60% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"1.5","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"No","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}